Enter your login e-mail to the account
Search
- Molecular markers of targeted therapy in oncology malignancies
RNDr. Katarína Hlinková
(2/2010, Review articles ) - Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFRmutant lung cancers
doc. MUDr. Peter Beržinec, CSc.
(6/2013, Information & comments ) - How to improve the first line treatment of NSCLC with EGFR mutation?
doc. MUDr. Peter Beržinec, CSc.
(6/2016, Review articles ) - Circulating tumor DNA in non-small cell lung cancer patients with epidermal growth factor receptor mutations
MUDr. Michal Urda, MUDr. Simona Laštíková, MUDr. Juraj Mazal, prof. MUDr. Eva Rozborilová, CSc.
(5/2020, Review articles ) - Exon 20 insertions and other uncommon EGFR mutations in non-small cell lung cancer
MUDr. Gabriela Chowaniecová, PhD., prof. MUDr. Dalibor Ondruš, DrSc.
(4/2023, Review articles ) - Non small-cell lung cancer and treatment options after tyrosine kinase inhibitors failure in the first line
MUDr. Gabriela Chowaniecová
(5/2014, Original articles & case reports ) - Dual EGFR mutation in patient with non-small cell lung cancer
MUDr. Martin Horný, MUDr. Lucia Doláková, MUDr. Kristína Šuhajdová, MUDr. Klaudia Grácová
(2/2023, Main topic ) - The role of osimertinib in the treatment of lung cancer
MUDr. Anna Kollárová
(1/2024, Drugs & drug classes ) - 17. svetová konferencia o karcinóme pľúc
Doc. MUDr. Peter Beržinec, CSc.
(1/2017, Events ) - Publikujeme v zahraničí
(1/2017, Information & comments )